NINGBO INNO PHARMCHEM CO.,LTD. highlights Pelitinib's (EKB-569) role as an irreversible pan-ErbB tyrosine kinase inhibitor and its importance as a pharmaceutical intermediate in the pursuit of new cancer therapies.
